The recent Corona pandemic taught us the importance of getting new diagnostics to market rapidly for keeping public life and the economy running. Join this online seminar to gain a clear overview of how to navigate from the development of your diagnostic, through intellectual property and financing issues, to market access. Meet our experts face-to-face to get tailored support for your diagnostic product.
This event is part of the Interreg NWE project Codex4SMEs which aims to support SMEs along the full diagnostics development value chain.
|13:00 – 13:10||Codex4SMEs – a support network for SMEs|
|13:10 – 13:30||A brief guide to patenting diagnostic inventionsby René Raggers | European Patent Attorney / Partner at AOMB Intellectual Property – an expert within the EATRIS networkWhat is possible in Europe?What in the USA?Brief remarks on strategy, Dos and Don’ts|
|13:30 – 13:50||Requirements of diagnostic SMEs from the perspective of investors by t.b.c.|
|13:50 – 14:10||Regulatory and Quality Compliance requirements to access the EU Diagnostics Marketby Greer Deal | Director at Med-Di-Dia – an expert within the Codex4SMEs Business Growth Programme|
|14:10 – 14:15||Q&A|
|14:15 – 15:00||One-to-one meetings via virtual matchmaking platform|
With the mission of “the right drug, at the right dose, at the right time, to the right patient“, the Interreg North-West Europe Codex4SMEs project funds the development of innovative diagnostics for improved personalised healthcare in Europe. The funding programme aims to support small and medium-sized (SME) companies in the life sciences and medical technology sectors engaged in the development of diagnostics. For the development of improved diagnostics, nine partners from six EU countries have launched a strong Fast Track Programme offering SMEs a wide range of services along the entire value chain.